Cutting edge: Expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters normal IRAK-4 interaction with components of the IL-1 receptor complex

被引:43
作者
Medvedev, AE
Thomas, K
Awomoyi, A
Kuhns, DB
Gallin, JI
Li, XX
Vogel, SN
机构
[1] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA
[2] Sci Applicat Int Corp Frederick Inc, Clin Serv Program, NCI, Frederick, MD 21702 USA
[3] NIAID, Lab Host Def, NIH, Bethesda, MD 20892 USA
[4] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA
关键词
D O I
10.4049/jimmunol.174.11.6587
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In a patient with recurrent bacterial infections and profound hyporesponsiveness to LPS and IL-1, we previously identified two mutations in IL-IR-associated kinase-4 (IRAK-4) that encoded proteins with truncated kinase domains. Overexpression of either of these mutant IRAK-4 variants in HEK293 cells failed to activate endogenous IRAK-1 and suppressed IL-1-induced IRAK-1 kinase activity, in contrast to wild-type (WT) IRAK-4. In this study, interactions of WIT and mutant IRAK-4 species with IL-1R, IRAK-1, and MyD88 in HEK293 transfectants were compared. IL-1 induced a strong interaction among the IL-1R, activated IRAK-1, MyD88, and WIT, but not mutant, IRAK-4. Truncated IRAK-4 proteins constitutively interacted more strongly with MyD88 and blunted IL-1-induced recruitment of IRAK-1 and MyD88 to the IL-1R. Thus, decreased IL-1-induced association of IRAK-1 and MyD88 with the IL-1RI may result from sequestration of cytoplasmic MyD88 by IRAK-4 mutant proteins. Therefore, mimetics of these truncated IRAK-4 proteins may represent a novel approach to mitigating hyperinflammatory states.
引用
收藏
页码:6587 / 6591
页数:5
相关论文
共 23 条
[1]   Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 [J].
Burns, K ;
Janssens, S ;
Brissoni, B ;
Olivos, N ;
Beyaert, R ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :263-268
[2]   MyD88, an adapter protein involved in interleukin-1 signaling [J].
Burns, K ;
Martinon, F ;
Esslinger, C ;
Pahl, H ;
Schneider, P ;
Bodmer, JL ;
Di Marco, F ;
French, L ;
Tschopp, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :12203-12209
[3]   TARF6 is a signal transducer for interleukin-1 [J].
Cao, ZD ;
Xiong, J ;
Takeuchi, M ;
Kurama, T ;
Goeddel, DV .
NATURE, 1996, 383 (6599) :443-446
[4]   TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide-stimulated macrophages [J].
Irie, T ;
Muta, T ;
Takeshige, K .
FEBS LETTERS, 2000, 467 (2-3) :160-164
[5]   ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway [J].
Kopp, E ;
Medzhitov, R ;
Carothers, J ;
Xiao, CC ;
Douglas, I ;
Janeway, CA ;
Ghosh, S .
GENES & DEVELOPMENT, 1999, 13 (16) :2059-2071
[6]  
Kuhns DB, 1997, J IMMUNOL, V158, P3959
[7]   IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase [J].
Li, SY ;
Strelow, A ;
Fontana, EJ ;
Wesche, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5567-5572
[8]   IL-1-induced NFκB and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK) [J].
Li, XX ;
Commane, M ;
Jiang, ZF ;
Stark, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4461-4465
[9]   Structure and function of Toll-like receptor proteins [J].
Means, TK ;
Golenbock, DT ;
Fenton, MJ .
LIFE SCIENCES, 2000, 68 (03) :241-258
[10]   Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections [J].
Medvedev, AE ;
Lentschat, A ;
Kuhns, DB ;
Blanco, JCG ;
Salkowski, C ;
Zhang, SL ;
Arditi, MH ;
Gallin, JI ;
Vogel, SN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (04) :521-531